LONG-TERM EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA BY BASELINE BODY MASS INDEX

被引：2
|
作者：
Chupp, Geoffrey L.
Lugogo, Njira L.
Wechsler, Michael E.
Lawson, Kaitlyn
Lindsley, Andrew
Spahn, Joe D.
Ambrose, Christopher
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.075
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：9A / 14A
页数：6
相关论文
共 50 条
  • [31] Effect of tezepelumab on healthcare utilization in patients with severe, uncontrolled asthma The NAVIGATOR study
    Menzies-Gow, Andrew
    Bourdin, Arnaud
    Chupp, Geoffrey
    Israel, Elliot
    Hellqvist, Asa
    Hunter, Gillian
    Roseti, Stephanie L.
    Ambrose, Christopher S.
    Llanos, Jean-Pierre
    Cook, Bill
    Corren, Jonathan
    Colice, Gene
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (03) : 343 - +
  • [32] Long-Term Safety and Efficacy of Mepolizumab in Patients with Severe Eosinophilic Asthma
    Albers, Frank C.
    Lugogo, Njira
    Gilson, Martyn J.
    Price, Robert
    Yancey, StevenW.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB14 - AB14
  • [33] Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials
    Corren, Jonathan
    Menzies-Gow, Andrew
    Chupp, Geoffrey
    Israel, Elliot
    Korn, Stephanie
    Cook, Bill
    Ambrose, Christopher S.
    Hellqvist, Asa
    Roseti, Stephanie L.
    Molfino, Nestor A.
    Llanos, Jean-Pierre
    Martin, Neil
    Bowen, Karin
    Griffiths, Janet M.
    Parnes, Jane R.
    Colice, Gene
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (01) : 13 - 24
  • [34] Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with Respiratory Comorbidities: Results from the Phase 3 NAVIGATOR Study
    Carr, Tara
    Bernstein, Jonathan
    Cook, Bill
    Hunter, Gillian
    Ambrose, Chris
    Llanos-Ackert, Jean-Pierre
    Lindsley, Andrew
    Colice, Gene
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB152 - AB152
  • [35] Tezepelumab for Patients with Severe Uncontrolled Asthma: A Systematic Review and Meta-Analysis
    Zoumot, Zaid
    Al Busaidi, Nasser
    Tashkandi, Wail
    Aljohaney, Ahmed A.
    Isse, Said
    Vidyasagar, Kota
    Ukwaja, Kingsley Nnanna
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 1665 - 1679
  • [36] Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo- controlled extension study (vol 11, pg 425, 2023)
    Menzies-Gow, A.
    Wechsler, M. E.
    Brightling, C. E.
    LANCET RESPIRATORY MEDICINE, 2023, 11 (03): : E25 - E25
  • [37] Efficacy of tezepelumab in patients with severe asthma and persistent airflow obstruction
    Israel, Elliot
    Castro, Mario
    Ambrose, Christopher S.
    Llanos, Jean-Pierre
    Molfino, Nestor A.
    Martin, Nicole L.
    Ponnarambil, Sandhia S.
    Martin, Neil
    ERJ OPEN RESEARCH, 2024, 10 (06)
  • [38] Tezepelumab Efficacy By SNOT-22 Score In Patients With Severe, Uncontrolled Asthma And Comorbid Nasal Polyps In NAVIGATOR
    Jacobs, Joshua
    Hoyte, Flavia
    Spahn, Joseph
    Ambrose, Chris
    Martin, Nicole
    Vong, Sylvia
    Caveney, Scott
    Cook, Bill
    Colice, Gene
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB17 - AB17
  • [39] Influence of Key Clinical Baseline Factors on Benralizumab Efficacy for Patients with Severe, Uncontrolled Asthma
    Bleecker, E. R.
    Wechsler, M. E.
    Fitzgerald, J. M.
    Menzies-Gow, A.
    Wu, Y.
    Hirsch, I.
    Goldman, M.
    Newbold, P.
    Zangrilli, J. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [40] Efficacy of tezepelumab in patients with severe, uncontrolled asthma and low blood eosinophil counts not receiving maintenance oral corticosteroids
    Menzies-Gow, A.
    Cook, B.
    Colice, G.
    Hellqvist, A.
    Llanos-Ackert, J. P.
    Ambrose, C. S.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
12345